Tlou Energy Limited (AIM:TLOU)

CTI BioPharma Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	2.52	6.85	7.88	6.39	1.58
Cash & Short-Term Investments	2.52	6.85	7.88	6.39	1.58
Cash Growth	-63.25%	-13.03%	23.33%	305.04%	-69.71%
Other Receivables	0.5	1.31	0.42	0.27	0.21
Receivables	0.5	1.31	0.42	0.27	0.21
Other Current Assets	0.66	1.14	0.18	0	0.09
Total Current Assets	3.68	9.3	8.48	6.65	1.87
Property, Plant & Equipment	73.28	61.84	50.55	49.7	49.44
Other Long-Term Assets	0.58	0.48	0.6	0.63	0.71
Total Assets	77.53	71.63	59.63	56.98	52.02
Accounts Payable	0.46	1.83	0.45	0.05	0.09
Accrued Expenses	1.47	0.95	0.42	0.38	0.3
Short-Term Debt	0.48	-	-	-	-
Current Portion of Leases	0.02	0.02	0.01	0.01	-
Other Current Liabilities	0.02	0.04	0.72	0.01	0.01
Total Current Liabilities	2.45	2.84	1.59	0.45	0.4
Long-Term Debt	12.2	10.09	7.26	-	-
Long-Term Leases	0.02	0.04	0.06	0.07	-
Other Long-Term Liabilities	0.27	0.26	0.18	0.11	0.11
Total Liabilities	14.94	13.22	9.09	0.63	0.51
Common Stock	130.02	121.51	106.76	106.76	99.75
Retained Earnings	-58.01	-53.76	-49.51	-45.19	-43.13
Comprehensive Income & Other	-9.42	-9.34	-6.72	-5.23	-5.12
Shareholders' Equity	62.59	58.41	50.53	56.35	51.51
Total Liabilities & Equity	77.53	71.63	59.63	56.98	52.02
Total Debt	12.72	10.14	7.33	0.09	-
Net Cash (Debt)	-10.2	-3.29	0.54	6.3	1.58
Net Cash Growth	-	-	-91.41%	299.57%	-69.71%
Net Cash Per Share	-0.01	-0.00	0.00	0.01	0.00
Filing Date Shares Outstanding	1,286	1,025	600.21	600.2	525.2
Total Common Shares Outstanding	1,270	1,025	600.2	600.2	450.18
Working Capital	1.23	6.46	6.88	6.21	1.47
Book Value Per Share	0.05	0.06	0.08	0.09	0.11
Tangible Book Value	62.59	58.41	50.53	56.35	51.51
Tangible Book Value Per Share	0.05	0.06	0.08	0.09	0.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.